Metabolic Diseases Completed Phase 1 Trials for Bococizumab (DB12456)
Also known as: Diseases, Metabolic / Metabolic Disease
Indication | Status | Phase |
---|---|---|
DBCOND0030621 (Metabolic Diseases) | Completed | 1 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT01435382 | A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia | Basic Science |